The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science
Open accessAbstract
Objective We wanted to identify the most promising methylation marker candidates for cervical cancer early detection. Methods A systematic literature review was performed in Medline and weighted average frequencies for methylated genes stratified by tissue source and methods used were computed. Results 51 studies were identified analyzing 68 different genes for methylation in 4376 specimens across all stages of cervical carcinogenesis. 15 genes, DAPK1, RASSF1, CDH1, CDKN2A, MGMT, RARB, APC, FHIT, MLH1, TIMP3, GSTP1, CADM1, CDH13, HIC1, and TERT have been analyzed in 5 or more studies. The published data on these genes is highly heterogeneous; 7 genes (CDH1, FHIT, TERT, CDH13, MGMT, TIMP3, and HIC1) had a reported range of methylation frequencies in cervical cancers of greater than 60% between studies. Stratification by analysis method did not resolve the heterogeneity. Three markers, DAPK1, CADM1, and RARB, showed elevated methylation in cervical cancers consistently across studies. Conclusions There is currently no methylation marker that can be readily translated for use in cervical cancer screening or triage settings. Large, well-conducted methylation profiling studies of cervical carcinogenesis could yield new candidates that are more specific for HPV-related carcinogenesis. New candidate markers need to be thoroughly validated in highly standardized assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Self-citationThe Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,144
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,100
The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology
Solomon, D., Davey, D., Kurman, R., Moriarty, A., O’Connor, D., Prey, M., Raab, S., Sherman, M., Wilbur, D., & Wright, T. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200208000-00015 · Cited by 822
Self-citationHuman Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797
Bulkmans, N., Berkhof, J., Rozendaal, L., van Kemenade, F., Boeke, A., Bulk, S., Voorhorst, F., Verheijen, R., van Groningen, K., Boon, M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61450-0 · Cited by 637
(2007) · PubMed Central · Cited by 309
Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong, S. M., Kim, H. S., Rha, S.-H., & Sidransky, D. (2001) · PubMed · Cited by 254
Cited by
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Steenbergen, R. D. M., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3728 · Cited by 386
Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes
Ho, S.-M., Johnson, A., Tarapore, P., Janakiram, V., Zhang, X., & Leung, Y.-K. (2012) · ILAR Journal · doi:10.1093/ilar.53.3-4.289 · Cited by 312
Metadata
- Authors
- Wentzensen, N., Sherman, M. E., Schiffman, M., & Wang, S. S.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 112
- Issue
- 2
- Pages
- 293-299
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W1963744267
- Cited by
- 263
- References
- 50
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science. https://app.cochat.ai/papers/10.1016/j.ygyno.2008.10.012
- The paper
- Wentzensen, N., Sherman, M. E., Schiffman, M., & Wang, S. S. (2009). Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2008.10.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.